Inaccuracy of Self-Completed COPD Assessment Test by Older Patients Leads to Underestimation of Disease Severity

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F20%3A10406177" target="_blank" >RIV/00216208:11150/20:10406177 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/20:00115253 RIV/65269705:_____/20:00072644 RIV/00179906:_____/20:10406177

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=xPKNk_Fu-l" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=xPKNk_Fu-l</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jamda.2019.02.001" target="_blank" >10.1016/j.jamda.2019.02.001</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Inaccuracy of Self-Completed COPD Assessment Test by Older Patients Leads to Underestimation of Disease Severity

Popis výsledku v původním jazyce

Chronic obstructive pulmonary disease (COPD), a life-threatening condition, represents a considerable public health and socioeconomic challenge.1 Symptoms of this long-lasting respiratory disease can significantly impair patients&apos; daily physical activities, reduce quality of life, and lead to excessive health care overuse.1,2 Modified Medical Research Council dyspnea scale is a basic tool for determining symptoms of dyspnea in COPD patients.3 However, because COPD subjects suffer from complex symptomatology, COPD Assessment Test (CAT), a validated patient-completed questionnaire, is now globally recommended as the first choice assessment tool to classify COPD individuals according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease, Inc) Strategy in daily practice.

Název v anglickém jazyce

Inaccuracy of Self-Completed COPD Assessment Test by Older Patients Leads to Underestimation of Disease Severity

Popis výsledku anglicky

Chronic obstructive pulmonary disease (COPD), a life-threatening condition, represents a considerable public health and socioeconomic challenge.1 Symptoms of this long-lasting respiratory disease can significantly impair patients&apos; daily physical activities, reduce quality of life, and lead to excessive health care overuse.1,2 Modified Medical Research Council dyspnea scale is a basic tool for determining symptoms of dyspnea in COPD patients.3 However, because COPD subjects suffer from complex symptomatology, COPD Assessment Test (CAT), a validated patient-completed questionnaire, is now globally recommended as the first choice assessment tool to classify COPD individuals according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease, Inc) Strategy in daily practice.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30203 - Respiratory systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of the American Medical Directors Association

ISSN

1525-8610

e-ISSN

—

Svazek periodika

21

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

3

Strana od-do

133-135

Kód UT WoS článku

000504685400027

EID výsledku v databázi Scopus

2-s2.0-85077017608